Evidence map›Paper›PMID 21639874›Full record

SynthesisBMC musculoskeletal disorders2011

Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response.

Sebastian Straube, R Andrew Moore, Jocelyn Paine, Sheena Derry, Ceri J Phillips, Ernst Hallier, Henry J McQuay

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMC musculoskeletal disorders, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 11 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 11 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Mirtazapine for fibromyalgia in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Combination pharmacotherapy for the treatment of fibromyalgia in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Pooled it
  7. Gabapentin for fibromyalgia pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  8. Antipsychotics for fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Pooled it
  9. Milnacipran for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2015
    Pooled it
  10. Pooled it
  11. Milnacipran for neuropathic pain and fibromyalgia in adults.The Cochrane database of systematic reviews · 2012
    Pooled it
  12. Trial
  13. Article
  14. Amitriptyline for fibromyalgia in adults.The Cochrane database of systematic reviews · 2019
    Review
  15. Article
  16. Pregabalin for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Review
  17. Oxycodone for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Review
  18. Review
  19. Article
  20. Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis.Journal of occupational medicine and toxicology (London, England) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Sebastian StraubeDepartment of Occupational, Social and Environmental Medicine, University Medical Center Göttingen, Germany. sebastian.straube@googlemail.com
R Andrew Moore
Jocelyn Paine
Sheena Derry
Ceri J Phillips
Ernst Hallier
Henry J McQuay
Churchill Hospital · GBSwansea University · GBUniversitätsmedizin Göttingen · DEUniversity of Göttingen · DEUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical trials in chronic pain often collect information about interference with work as answers to component questions of commonly used questionnaires but these data are not normally analysed separately.

methodsWe performed a meta-analysis of individual patient data from four large trials of pregabalin for fibromyalgia lasting 8-14 weeks. We analysed data on interference with work, inferred from answers to component questions of Fibromyalgia Impact Questionnaire (FIQ), Short Form 36 Health Survey, Sheehan Disability Scale, and Multidimensional Assessment of Fatigue, including "How many days in the past week did you miss work, including housework, because of fibromyalgia?" from FIQ. Analyses were performed according to randomised treatment group (pregabalin 150-600 mg daily or placebo), pain improvement (0-10 numerical pain rating scale scores at trial beginning vs. end), and end of trial pain state (100 mm visual analogue pain scale [VAS]).

resultsComparing treatment group average outcomes revealed modest improvement over the duration of the trials, more so with active treatment than with placebo. For the 'work missed' question from FIQ the change for patients on placebo was from 2.2 (standard deviation [SD] 2.3) days of work lost per week at trial beginning to 1.9 (SD 2.1) days lost at trial end (p < 0.01). For patients on 600 mg pregabalin the change was from 2.1 (SD 2.2) days to 1.6 (SD 2.0) days (p < 0.001). However, the change in days of work lost was substantial in patients with a good pain response: from 2.0 (SD 2.2) days to 0.97 (SD 1.6) days (p < 0.0001) for those experiencing >/= 50% pain improvement and from 1.9 (SD 2.2) days to 0.73 (SD 1.4) days (p < 0.0001) for those achieving a low level of pain at trial end (<30 mm on the VAS). Patients achieving both >/= 50% pain improvement and a pain score <30 mm on the VAS had the largest improvement, from 2.0 (SD 2.2) days to 0.60 (SD 1.3) days (p < 0.0001). Analysing answers to the other questions yielded qualitatively similar results.

conclusionsEffective pain treatment goes along with benefit regarding work. A reduction in time off work >1 day per week can be achieved in patients with good pain responses.

Indexed as

AbsenteeismActivities of Daily LivingAdolescentAdultAgedAged, 80 and overAnalgesicsCost of IllnessFemaleFibromyalgiagamma-Aminobutyric AcidHumansMaleMiddle AgedPainPain MeasurementAnalgesicsgamma-Aminobutyric AcidPregabalin

Identifiers

PMID21639874
PMCPMC3118156
OpenAlexW2141486538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.